Fuller & Thaler Asset Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $988K | Buy |
|
|||||
|
2025
Q2 | $685K | Sell |
|
|||||
|
2025
Q1 | $717K | Sell |
|
|||||
|
2024
Q4 | $1.49M | Buy |
|
|||||
|
2024
Q3 | $1.3M | Sell |
|
|||||
|
2024
Q2 | $5.05M | Sell |
|
|||||
|
2024
Q1 | $1.96M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $46.8M | Buy |
|
|||||
|
2020
Q4 | $25.7M | Buy |
|
|||||
|
2020
Q3 | $19.8M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $10.1M | Buy |
|
|||||
|
2018
Q4 | $11.5M | Sell |
|
|||||
|
2018
Q3 | $13.6M | Sell |
|
|||||
|
2018
Q2 | $10.9M | Buy |
|
|||||
|
2018
Q1 | $11.3M | Sell |
|
|||||
|
2017
Q4 | $10.3M | Buy |
|